Critical Care

official impact factor 4.60

Review

Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification

Pierre-François Laterre* and Xavier Wittebole

Critical Care 2003, 7:445-450 doi:10.1186/cc2342

No comments have yet been made on this article.

Post a comment